Standard operating procedure

Medication Diversion & Misuse Prevention Procedure

How [Organisation Name] prescribes stimulant controlled drugs for attention deficit hyperactivity disorder safely, recognises and responds to possible diversion or misuse, and protects patients without unfairly denying treatment to those with a genuine clinical need

For ADHD ClinicRef BS-ADH-SOP-010See a sample (PDF) →
£39.99
One-off purchase · no VAT · instant download
  • Instant download after checkout
  • Editable Microsoft Word (.docx)
  • Mapped to the CQC standards
  • Optional 3-monthly updates

What's inside

This standard operating procedure is fully drafted and structured, ready to brand and complete for your service. It covers:

  • 1. Purpose
  • 2. Scope
  • 3. Definitions and abbreviations
  • 4. Responsibilities
  • 5. Procedure
  • 6. Documentation and records
  • 7. Related documents
  • 8. Review and version control
  • 9. Disclaimer

Legislation & standards it maps to

  • Misuse of Drugs Act 1971
  • Misuse of Drugs Regulations 2001 (as amended)
  • The Controlled Drugs (Supervision of Management and Use) Regulations 2013
  • National Institute for Health and Care Excellence, Attention deficit hyperactivity disorder: diagnosis and management, NICE guideline NG87 (2018, updated 2019)
  • Health and Social Care Act 2008 (Regulated Activities) Regulations 2014 - Regulation 12 (Safe care and treatment)
  • Care Quality Commission single assessment framework
  • Data Protection Act 2018 and the UK General Data Protection Regulation

Who it applies to

All consultant psychiatrists, specialist doctors, non-medical prescribers and specialist nurses who assess, prescribe or review stimulant medication, together with pharmacists, prescription clerks, reception and administrative staff who handle prescriptions or patient requests, the Controlled Drugs Accountable Officer (CDAO) or the person fulfilling that function, and the registered manager or [Insert Job Title] at [Organisation Name]

Glossary

Plain-English explanations of the technical terms and legislation used in this document.

Adherence
The extent to which a patient takes a medicine exactly as it was prescribed.
Attention deficit hyperactivity disorder (ADHD)
A condition affecting attention, activity levels and impulse control, often treated with stimulant medicines.
Care Quality Commission (CQC)
The independent regulator of health and social care services in England.
Contemporaneously
Recorded at the time something happens, or as soon as possible afterwards, so the record is accurate and reliable.
Controlled drug (CD)
A medicine whose supply, storage and records are tightly restricted by law because of its potential for misuse.
Controlled Drugs Accountable Officer (CDAO)
The senior person legally responsible for the safe management and use of controlled drugs, to whom related concerns are reported.
Data Protection Act 2018
The UK law that governs how organisations collect, store and use people's personal information.
Dexamfetamine
A stimulant medicine used to treat ADHD; it is a Schedule 2 controlled drug.
Diversion
When a medicine prescribed for one patient is passed to someone else or used illicitly, for example sold, shared or given away.
Formulation
The particular form a medicine comes in, such as an immediate-release or modified-release tablet or capsule.
GP (general practitioner)
A family doctor who provides general medical care and often shares responsibility for a patient's ongoing treatment.
Health and Social Care Act 2008 (Regulated Activities) Regulations 2014
The regulations setting out the fundamental standards that registered care providers must meet, enforced by the Care Quality Commission.
Lisdexamfetamine
A stimulant medicine used to treat ADHD; it is a Schedule 2 controlled drug.
Local intelligence network
A group that shares information between organisations to spot and respond to concerns about how controlled drugs are being managed or used.
Methylphenidate
A stimulant medicine commonly used to treat ADHD; it is a Schedule 2 controlled drug.
Misuse
Using a medicine in a way other than prescribed, such as taking too much or using it for a non-medical effect.
Misuse of Drugs Act 1971
The main UK law controlling drugs that are liable to be misused, including how they may be supplied and possessed.
Misuse of Drugs Regulations 2001
The regulations that classify controlled drugs into schedules and set the rules for prescribing, storing and keeping records of them.
National Institute for Health and Care Excellence (NICE)
The national body that produces evidence-based guidance on treatments and care, including ADHD guideline NG87.
Near miss
An event that could have caused harm but did not, by chance or because it was caught in time.
Non-medical prescriber
A trained healthcare professional, such as a nurse or pharmacist, who is qualified to prescribe medicines without being a doctor.
Reconciliation
Comparing how much medicine has been prescribed and supplied against how much should have been used, to spot any unexplained difference.
Red flag
A warning sign or pattern that prompts closer clinical attention, here to the possibility of diversion or misuse.
Registered manager
The person registered with the regulator as responsible for the day-to-day running of a service.
Regulation 12 (Safe care and treatment)
The part of the Care Quality Commission's regulations requiring care and treatment to be provided safely and to avoid avoidable harm.
Responsible prescriber
The clinician with prescribing responsibility for a patient, who decides on the medicine, quantity, interval and whether to continue it.
Safeguarding
Protecting people's health, wellbeing and rights and keeping them safe from abuse, harm or neglect.
Schedule 2 controlled drug
A category of controlled drug with strict legal requirements for prescribing, recording and storage, which includes ADHD stimulants.
Shared care
An arrangement where responsibility for a patient's treatment is agreed and divided between two prescribers, such as a specialist and a GP.
Standard Operating Procedure (SOP)
A written, step-by-step instruction setting out how a particular task or process should be carried out consistently and safely.
Stimulant
A type of medicine that increases activity in parts of the brain, used as a first-line treatment for ADHD.
The Controlled Drugs (Supervision of Management and Use) Regulations 2013
The regulations requiring organisations to have systems and an accountable officer to oversee the safe use of controlled drugs.
Titration
Gradually adjusting the dose of a medicine, usually at the start of treatment, to find the amount that works best with the fewest side effects.
UK General Data Protection Regulation (UK GDPR)
The UK's main data-protection law governing how personal information is collected and used.

How it works

  1. Buy securely with Stripe - instant, no VAT, no account needed.
  2. Download your editable Word file from the link we email you straight away.
  3. Complete the placeholders for your service, then have it approved before use.
  4. Add the optional updates subscription and we keep it current as guidance changes.

Related documents

PolicyADHD Assessment Policy£54.99
PolicyMedication Management Policy£54.99
PolicySafeguarding Children Policy£54.99
PolicyConsent & Capacity Policy£54.99

Need the whole set?

Buy the full ADHD Clinic pack and save versus buying documents individually.

View the ADHD Clinic pack